Safety and efficacy of suprachoroidal triamcinolone acetonide for the management of serous choroidal detachment prior to rhegmatogenous retinal detachment surgery : A Pilot study
Purpose: To study the safety and efficacy of pre-operative suprachoroidal triamcinolone acetonide (SCTA) for achieving reduction/resolution of serous choroidal detachment (CD) associated with rhegmatogenous retinal detachment (RRD).
Methods: This was a prospective, noncomparative, interventional pilot study. All consecutive patients presenting with RD and coexisting CD underwent transconjunctival injection of SCTA before proceeding with vitrectomy/scleral buckle surgery. Sequential ultrasound B scans were performed for assessing the change in height of the CD.
Results: The mean age of the cohort was 53.8 ± 10.8 years (range: 39-72 years). The CD was present in a median of 3 quadrants; the cumulative mean CD height was 5.59 mm (range: 2.02-9.42 mm). Following SCTA, a successful response (>50% reduction) was seen in five eyes by day 3 and in two eyes by day 5. Three eyes failed to respond to SCTA and required surgical drainage before proceeding with vitrectomy. No intraprocedural injection-related complications were noted. A transient rise in the intraocular pressure (30 mmHg) was seen in one eye following vitrectomy and was managed successfully with topical antiglaucoma medications.
Conclusion: Suprachoroidal administration of triamcinolone appears to be a safe and effective technique to achieve CD resolution in eyes with RRD.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2022 |
|---|---|
| Erschienen: |
2022 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:70 |
|---|---|
| Enthalten in: |
Indian journal of ophthalmology - 70(2022), 4 vom: 25. Apr., Seite 1302-1306 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Kohli, Gaurav Mohan [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Choroidal detachment |
|---|
| Anmerkungen: |
Date Completed 13.04.2022 Date Revised 16.07.2022 published: Print Citation Status MEDLINE |
|---|
| doi: |
10.4103/ijo.IJO_1788_21 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM33856330X |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM33856330X | ||
| 003 | DE-627 | ||
| 005 | 20231226000944.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2022 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.4103/ijo.IJO_1788_21 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1128.xml |
| 035 | |a (DE-627)NLM33856330X | ||
| 035 | |a (NLM)35326041 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Kohli, Gaurav Mohan |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Safety and efficacy of suprachoroidal triamcinolone acetonide for the management of serous choroidal detachment prior to rhegmatogenous retinal detachment surgery |b A Pilot study |
| 264 | 1 | |c 2022 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 13.04.2022 | ||
| 500 | |a Date Revised 16.07.2022 | ||
| 500 | |a published: Print | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Purpose: To study the safety and efficacy of pre-operative suprachoroidal triamcinolone acetonide (SCTA) for achieving reduction/resolution of serous choroidal detachment (CD) associated with rhegmatogenous retinal detachment (RRD) | ||
| 520 | |a Methods: This was a prospective, noncomparative, interventional pilot study. All consecutive patients presenting with RD and coexisting CD underwent transconjunctival injection of SCTA before proceeding with vitrectomy/scleral buckle surgery. Sequential ultrasound B scans were performed for assessing the change in height of the CD | ||
| 520 | |a Results: The mean age of the cohort was 53.8 ± 10.8 years (range: 39-72 years). The CD was present in a median of 3 quadrants; the cumulative mean CD height was 5.59 mm (range: 2.02-9.42 mm). Following SCTA, a successful response (>50% reduction) was seen in five eyes by day 3 and in two eyes by day 5. Three eyes failed to respond to SCTA and required surgical drainage before proceeding with vitrectomy. No intraprocedural injection-related complications were noted. A transient rise in the intraocular pressure (30 mmHg) was seen in one eye following vitrectomy and was managed successfully with topical antiglaucoma medications | ||
| 520 | |a Conclusion: Suprachoroidal administration of triamcinolone appears to be a safe and effective technique to achieve CD resolution in eyes with RRD | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Choroidal detachment | |
| 650 | 4 | |a needle | |
| 650 | 4 | |a retinal detachment | |
| 650 | 4 | |a suprachoroidal | |
| 650 | 4 | |a triamcinolone acetonide | |
| 650 | 7 | |a Triamcinolone Acetonide |2 NLM | |
| 650 | 7 | |a F446C597KA |2 NLM | |
| 700 | 1 | |a Shenoy, Pratik |e verfasserin |4 aut | |
| 700 | 1 | |a Halim, Danish |e verfasserin |4 aut | |
| 700 | 1 | |a Nigam, Saurabh |e verfasserin |4 aut | |
| 700 | 1 | |a Shetty, Sachin |e verfasserin |4 aut | |
| 700 | 1 | |a Talwar, Dinesh |e verfasserin |4 aut | |
| 700 | 1 | |a Sen, Alok |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Indian journal of ophthalmology |d 1971 |g 70(2022), 4 vom: 25. Apr., Seite 1302-1306 |w (DE-627)NLM000735493 |x 1998-3689 |7 nnns |
| 773 | 1 | 8 | |g volume:70 |g year:2022 |g number:4 |g day:25 |g month:04 |g pages:1302-1306 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.4103/ijo.IJO_1788_21 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 70 |j 2022 |e 4 |b 25 |c 04 |h 1302-1306 | ||